公开(公告)号：US20200060969A1

公开(公告)日：2020-02-27

申请号：US16669692

申请日：2019-10-31

Applicant: CRITITECH, INC.

Inventor： Michael Baltezor ,  Matthew McClorey ,  William Johnston ,  Gere S. diZerega ,  James Verco

IPC: A61K9/00 ,  A61K31/337 ,  A61K9/16 ,  A61K9/10 ,  A61P35/00 ,  A61P11/00 ,  A61K47/26 ,  A61K47/02 ,  A61K9/14

Abstract: Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

公开(公告)号：US10507181B2

公开(公告)日：2019-12-17

申请号：US16444299

申请日：2019-06-18

Applicant: CRITITECH, INC.

Inventor： Michael Baltezor ,  Matthew McClorey ,  William Johnston ,  Gere S. diZerega ,  James Verco

IPC: A61K9/00 ,  A61K31/337 ,  A61K9/10 ,  A61P35/00 ,  A61K9/16 ,  A61K47/02 ,  A61K9/14 ,  A61K47/26 ,  A61P11/00

Abstract: Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

公开(公告)号：US20180360748A1

公开(公告)日：2018-12-20

申请号：US16007095

申请日：2018-06-13

Applicant: CRITITECH, INC.

Inventor： Michael Baltezor ,  Matthew McClorey ,  William Johnston ,  Gere S. diZerega ,  James Verco

IPC: A61K9/00 ,  A61P11/00 ,  A61P35/00 ,  A61K31/337 ,  A61K9/10 ,  A61K9/16

CPC classification number: A61K9/0078 ,  A61K9/10 ,  A61K9/14 ,  A61K9/1611 ,  A61K9/1623 ,  A61K31/337 ,  A61K47/02 ,  A61K47/26 ,  A61P11/00 ,  A61P35/00

Abstract: Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

公开(公告)号：US11160754B2

公开(公告)日：2021-11-02

申请号：US16669692

申请日：2019-10-31

Applicant: CRITITECH, INC.

Inventor： Michael Baltezor ,  Matthew McClorey ,  William Johnston ,  Gere S. diZerega ,  James Verco

IPC: A61K9/00 ,  A61P11/00 ,  A61P35/00 ,  A61K9/16 ,  A61K9/10 ,  A61K31/337 ,  A61K9/14 ,  A61K47/02 ,  A61K47/26

Abstract: Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

公开(公告)号：US20190314277A1

公开(公告)日：2019-10-17

申请号：US16444299

申请日：2019-06-18

Applicant: CRITITECH, INC.

Inventor： Michael Baltezor ,  Matthew McClorey ,  William Johnston ,  Gere S. diZerega ,  James Verco

IPC: A61K9/00 ,  A61K31/337 ,  A61K9/10 ,  A61P35/00 ,  A61P11/00 ,  A61K47/02 ,  A61K9/16 ,  A61K9/14 ,  A61K47/26

Abstract: Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

公开(公告)号：US10398646B2

公开(公告)日：2019-09-03

申请号：US16007095

申请日：2018-06-13

Applicant: CRITITECH, INC.

Inventor： Michael Baltezor ,  Matthew McClorey ,  William Johnston ,  Gere S. diZerega ,  James Verco

IPC: A61K9/00 ,  A61P11/00 ,  A61P35/00 ,  A61K9/16 ,  A61K9/10 ,  A61K31/337 ,  A61K47/02 ,  A61K47/26 ,  A61K9/14

Abstract: Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.